STOCK TITAN

Stonegate Initiates Coverage on SES AI Corp. (SES)

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
AI

SES AI (NYSE: SES) received initial research coverage from Stonegate Capital Partners following its 1Q26 update.

The company is shifting from EV battery R&D toward a commercialization model led by ESS, with drone cells, materials, and Molecular Universe supporting clearer 2H26 and 2027 revenue paths. 1Q26 revenue beat expectations, aided by ~$1.5M timing shift, while FY26 revenue guidance of $30M–$35M was reaffirmed.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Shift from EV battery R&D toward ESS-led commercialization model
  • ESS expected to anchor FY26 revenue contribution
  • 1Q26 revenue exceeded expectations despite timing benefit
  • FY26 revenue guidance reaffirmed at $30M–$35M
  • Drone cells and materials highlighted as 2H26 and 2027 growth paths
  • NDAA-compliant drone cell samples now shipping with defense interest building

Negative

  • 1Q26 revenue beat partly driven by ~$1.5M revenue shift from 4Q25

News Market Reaction – SES

+8.27%
11 alerts
+8.27% News Effect
+3.2% Peak Tracked
-5.4% Trough Tracked
+$41M Valuation Impact
$531.77M Market Cap
0.3x Rel. Volume

On the day this news was published, SES gained 8.27%, reflecting a notable positive market reaction. Argus tracked a peak move of +3.2% during that session. Argus tracked a trough of -5.4% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $41M to the company's valuation, bringing the market cap to $531.77M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Revenue timing shift: $1.5M FY26 revenue guidance: $30M–$35M Q1 2026 revenue: $6.7M +5 more
8 metrics
Revenue timing shift $1.5M 4Q25 revenue shifted into 1Q26
FY26 revenue guidance $30M–$35M Reaffirmed full-year 2026 guidance
Q1 2026 revenue $6.7M Reported in Q1 2026 results release
Q1 2026 GAAP net loss $12.1M First quarter 2026
Q1 2026 non-GAAP loss $11.1M First quarter 2026
Q1 2026 gross margin 18.1% Improved from 11.3% in prior period
Liquidity $178M As cited in Q1 2026 earnings
Shelf registration size $300,000,000 Registered securities under Form S-3 shelf

Peers on Argus

SES is up about 1.53% with mixed peer action: INVZ and SLDP show gains, while ML...
1 Up

SES is up about 1.53% with mixed peer action: INVZ and SLDP show gains, while MLR, HLLY, and MNRO are down. Only one momentum-peer (MVST, up ~6.16%) appears, supporting a stock-specific response to this coverage initiation.

Previous AI Reports

5 past events · Latest: Apr 23 (Neutral)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Apr 23 CFO transition Neutral -4.9% Management change with new CFO following Q1 2026 reporting cycle.
Apr 01 Business update Positive -1.2% Q1 2026 revenue pre-announcement and affirmation of FY26 guidance.
Mar 10 Event calendar Neutral +8.6% March 2026 investor and technical conference participation schedule.
Jan 05 Event calendar Neutral +10.9% January 2026 event lineup including CES and research conferences.
Dec 18 Drone collaboration Positive +5.5% Korea capacity expansion plan for drone and UAM lithium‑metal cells.
Pattern Detected

AI-tagged news has often produced positive moves, but business updates and management changes have sometimes seen muted or negative reactions.

Recent Company History

Over the last six months, SES AI’s AI-tagged headlines have focused on events, business updates, and strategic collaborations. Event calendars in Jan and Mar 2026 produced gains of 10.94% and 8.55%, while an AI‑focused drone manufacturing collaboration in Dec 2025 moved the stock up 5.49%. By contrast, the Apr 1 AI business update and Apr 23 CFO transition saw modest declines. Today’s coverage note continues the AI‑commercialization narrative around ESS and drones.

Historical Comparison

+3.8% avg move · In the past 12 months, SES has issued 5 AI‑tagged announcements with an average move of 3.77%. Today...
AI
+3.8%
Average Historical Move AI

In the past 12 months, SES has issued 5 AI‑tagged announcements with an average move of 3.77%. Today’s AI‑focused coverage note and commercialization update fits this pattern of AI‑driven strategic news.

AI‑tagged news has progressed from event calendars and AI‑enhanced collaborations to concrete business updates around ESS, drones, and commercialization milestones.

Regulatory & Risk Context

Active S-3 Shelf · $300,000,000 · Short Interest: 8.38%
Shelf Active
Short Interest
8.38% of shares outstanding
as of 2026-05-29 Days to cover: 2.11
Active S-3 Shelf Registration 2026-04-24
$300,000,000 registered capacity

An effective Form S-3 shelf filed on 2026-04-24 registers up to $300,000,000 of securities and includes an at-the-market program for up to $150,000,000 of Class A common stock, providing flexibility to raise capital under specified terms.

Market Pulse Summary

The stock moved +8.3% in the session following this news. A strong positive reaction aligns with rec...
Analysis

The stock moved +8.3% in the session following this news. A strong positive reaction aligns with recent AI‑tagged updates that previously averaged moves of about 3.77%. The coverage highlights SES’s shift from EV R&D toward ESS‑led commercialization, drones, and materials, alongside reaffirmed $30M–$35M FY26 guidance. However, an effective $300,000,000 shelf and ATM capacity provide significant capital-raising flexibility that could influence future supply of shares.

Key Terms

ndaA-compliant, molecular universe
2 terms
ndaA-compliant regulatory
"Drone cells are the key upside variable, with NDAA-compliant samples shipping"
NDAA-compliant means that a product, supplier, or company meets the rules in the U.S. National Defense Authorization Act that bar certain foreign technologies and require specific security practices. For investors, compliance matters because it determines whether a business can sell to the U.S. government, avoid fines or bans, and reduce supply‑chain or reputational risk—similar to passing a background check that lets you bid on a sensitive contract.
molecular universe technical
"materials, and Molecular Universe adding clearer 2H26/2027 revenue paths"
The molecular universe is the full set of biological molecules—such as proteins, genes, or small chemical compounds—that a research program or technology platform can detect, target, or manipulate. For investors it signals the size and diversity of a company’s potential pipeline and commercial opportunities, like seeing how many different rooms a master key could open; a larger molecular universe usually means more future drug candidates and revenue paths.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Dallas, Texas--(Newsfile Corp. - June 2, 2026) - SES AI Corp. (NYSE: SES): Stonegate Capital Partners Initiates Coverage on SES AI Corp. (NYSE: SES). SES' 1Q26 update further shifts the story from EV battery development toward a commercialization model led by ESS, with drone cells, materials, and Molecular Universe adding clearer 2H26/2027 revenue paths. Revenue beat expectations, though Q1 benefited from ~$1.5M of 4Q25 revenue shifting into the period, so the better read is not run-rate extrapolation but improved mix, reaffirmed FY26 guidance, and better visibility into drone qualification, cost reductions, and AI-enabled product differentiation.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • SES is shifting from EV R&D toward commercialization, with ESS anchoring FY26 revenue and drone cells/materials adding clearer 2H26 and 2027 growth paths.

  • 1Q26 revenue beat was helped by timing, but stronger gross margin, improved mix, and reaffirmed $30M-$35M guidance support execution credibility.

  • Drone cells are the key upside variable, with NDAA-compliant samples shipping, defense interest building, and qualification potentially converting into fuller 2027 deliveries.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/12376/299818_figure1.jpg

Click image above to view full announcement.


About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299818

FAQ

What did Stonegate Capital Partners announce about SES AI (NYSE: SES) on June 2, 2026?

Stonegate Capital Partners announced it has initiated research coverage on SES AI (NYSE: SES). The coverage highlights SES AI’s shift from EV battery R&D toward an ESS-led commercialization model, emphasizing revenue visibility into 2H26 and 2027 from ESS, drone cells, and materials.

How is SES AI’s business model evolving according to the June 2026 Stonegate coverage?

SES AI’s model is described as moving from EV battery development to commercialization focused on ESS. Stonegate notes ESS should anchor FY26 revenue, while drone cells, materials, and Molecular Universe provide clearer revenue paths in the second half of 2026 and into 2027.

Did SES AI’s 1Q26 revenue beat expectations, and what influenced the result for SES stock?

1Q26 revenue for SES AI beat expectations, but part of the upside came from timing. According to Stonegate, about $1.5 million of 4Q25 revenue shifted into 1Q26, so investors are encouraged to focus on improved mix, margins, and guidance rather than run-rate extrapolation.

What FY26 revenue guidance did SES AI provide, and how does it support SES (NYSE: SES) investors?

SES AI reaffirmed FY26 revenue guidance of $30 million to $35 million. According to SES, this guidance, supported by stronger gross margin and improved revenue mix, is viewed in the coverage as backing the company’s execution credibility and commercialization progress in ESS and related products.

Why are drone battery cells important to SES AI’s 2027 outlook?

Drone cells are highlighted as the key upside variable for SES AI’s 2027 outlook. Stonegate notes NDAA-compliant samples are already shipping, defense interest is building, and successful qualification could potentially translate into fuller delivery volumes in 2027, benefiting future revenue.

What role does ESS play in SES AI’s revenue strategy for FY26?

ESS is expected to anchor SES AI’s FY26 revenue within its commercialization strategy. The coverage explains that ESS leads the revenue model, while drone cells, materials, and Molecular Universe complement growth, offering more defined revenue paths for the second half of 2026 and beyond.